Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh
By: Junichi Ishigami, Md. Mahmudul Hasan, Aruna Sarker, Sharmin Nahar, Sibly Sadik Shuvo, Mir Ishraquzzaman, Mohammad Abdullah Al Mamun, Md. Kalimuddin, Sheikh Mohammad Mahbubus Sobhan, Di Zhao, Kunihiro Matsushita, Lawrence J. Appel, Sohel Reza Choudhury, Edgar R. Miller III and Fazila-Tun-Nesa Malik
References
- Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–450. DOI: 10.1161/CIRCULATIONAHA.115.018912
- Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet. 2016;387(10022):957–967. DOI: 10.1016/S0140-6736(15)01225-8
- Guerrero-Garcia C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. Drugs in Context. 2018;7:
212531 . DOI: 10.7573/dic.212531 - Kishore SP, Salam A, Rodgers A, Jaffe MG, Frieden T. Fixed-dose combinations for hypertension. Lancet. 2018;392(10150):819–820. DOI: 10.1016/s0140-6736(18)31814-2
- Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: A meta-analysis. The American Journal of Medicine. 2007;120(8):713–719. DOI: 10.1016/j.amjmed.2006.08.033
- Weir MR, Rolfe M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clinical Journal of the American Society of Nephrology (CJASN). 2010;5(3):531–548. DOI: 10.2215/CJN.07821109
- Riaz BK, Islam MZ, Islam ANM, Zaman MM, Hossain MA, Rahman MM, et al. Risk factors for non-communicable diseases in Bangladesh: Findings of the population-based cross-sectional national survey 2018. BMJ open. 2020;10(11):
e041334 . DOI: 10.1136/bmjopen-2020-041334 - Hossain A, Suhel SA, Chowdhury SR, Islam S, Akther N, Dhor NR, et al. Hypertension and undiagnosed hypertension among Bangladeshi adults: Identifying prevalence and associated factors using a nationwide survey. Frontiers in Public Health. 2022;10:
1066449 . DOI: 10.3389/fpubh.2022.1066449 - Malik FT, Al Mamun MA, Choudhury SR, Ishraquzzaman M, Kalimuddin M, Huq TS, et al. May Measurement Month 2021: An analysis of blood pressure screening results from Bangladesh. European Heart Journal Supplements. 2024;26(Suppl 3):iii17–iii19. DOI: 10.1093/eurheartjsupp/suae041
- Lu Y, Tang O, Brady TM, Miller
III ER, Heiss G, Appel LJ, et al. Simplified blood pressure measurement approaches and implications for hypertension screening: The Atherosclerosis Risk in Communities study. Journal of Hypertension. 2021;39(3):447–452. DOI: 10.1097/HJH.0000000000002682 - World Health Organization. WHO model list of essential medicines, 21st List, 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
- Cohn JN, Kowey PR, Whelton PK, Prisant LM. New guidelines for potassium replacement in clinical practice: A contemporary review by the National Council on Potassium in Clinical Practice. Archives of Internal Medicine. 2000;160(16):2429–2436. DOI: 10.1001/archinte.160.16.2429
- Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. The New England Journal of Medicine. 2004;351(6):585–592. DOI: 10.1056/NEJMra035279
- Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, et al. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial. European Journal of Preventive Cardiology. 2014;21(3):299–309. DOI: 10.1177/2047487313510678
- Teo K, Yusuf S, Sleight P, Anderson C, Mookadam F, Ramos B, et al. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. American Heart Journal. 2004;148(1):52–61. DOI: 10.1016/j.ahj.2004.03.020
- Parikh RV, Nash DM, Brimble KS, Markle-Reid M, Tan TC, McArthur E, et al. Kidney function and potassium monitoring after initiation of renin-angiotensin-aldosterone system blockade therapy and outcomes in 2 North American populations. Circulation Cardiovascular Quality and Outcomes. 2020;13(9):
e006415 . DOI: 10.1161/CIRCOUTCOMES.119.006415 - Bandak G, Sang Y, Gasparini A, Chang AR, Ballew SH, Evans M, et al. Hyperkalemia after initiating renin-angiotensin system blockade: The Stockholm Creatinine Measurements (SCREAM) Project. Journal of the American Heart Association. 2017;6(7):
e005428 . DOI: 10.1161/JAHA.116.005428 - Reddin C, Ferguson J, Murphy R, Clarke A, Judge C, Griffith V, et al. Global mean potassium intake: A systematic review and Bayesian meta-analysis. European Journal of Nutrition. 2023;62(5):2027–2037. DOI: 10.1007/s00394-023-03128-6
- Ojji DB, Mayosi B, Francis V, Badri M, Cornelius V, Smythe W, et al. Comparison of dual therapies for lowering blood pressure in Black Africans. The New England Journal of Medicine. 2019;380(25):2429–2439. DOI: 10.1056/NEJMoa1901113
- Neldam S, Lang M, Jones R, TEAMSTA-5 Investigators T. Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: Results of the TEAMSTA-5 study. Journal of Clinical Hypertension. 2011;13(7):459–466. DOI: 10.1111/j.1751-7176.2011.00468.x
- Rodenburg EM, Visser LE, Hoorn EJ, Ruiter R, Lous JJ, Hofman A, et al. Thiazides and the risk of hypokalemia in the general population. Journal of Hypertension. 2014;32(10):2092–2097; discussion 2097. DOI: 10.1097/HJH.0000000000000299
- Volpe M, Gallo G, Tocci G. Is early and fast blood pressure control important in hypertension management? International Journal of Cardiology. 2018;254:328–332. DOI: 10.1016/j.ijcard.2017.12.026
- Salam A, Kanukula R, Atkins E, Wang X, Islam S, Kishore SP, et al. Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: A systematic review and meta-analysis of randomized controlled trials. Journal of Hypertension. 2019;37(9):1768–1774. DOI: 10.1097/HJH.0000000000002096
- Moore MN, Atkins ER, Salam A, Callisaya ML, Hare JL, Marwick TH, et al. Regression to the mean of repeated ambulatory blood pressure monitoring in five studies. Journal of Hypertension. 2019;37(1):24–29. DOI: 10.1097/HJH.0000000000001977
- Abernethy DR. Pharmacokinetics and pharmacodynamics of amlodipine. Cardiology. 1992;80 Suppl 1:31–36. DOI: 10.1159/000175050
- National Committee for Quality Assurance. Annual Monitoring for Patients on Persistent Medications (MPM) [Internet]. Washington, DC: National Committee for Quality Assurance; [cited 2023 Oct 31]. Available from:
https://www.ncqa.org/annual-monitoring-for-patients-on-persistent-medications/ . - Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, et al. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiology and Drug Safety. 2007;16(1):55–64. DOI: 10.1002/pds.1217
- Bootsma JE, Warle-van Herwaarden MF, Verbeek AL, Füssenich P, De Smet PAGM, Rikkert MGO, et al. Adherence to biochemical monitoring recommendations in patients starting with renin angiotensin system inhibitors: A retrospective cohort study in the Netherlands. Drug Safety. 2011;34(7):605–614. DOI: 10.2165/11587250-000000000-00000
- Porcher R, Tran VT, Blacher J, Ravaud P. Potential of stratified medicine for high blood pressure management: A modeling study using NHANES survey data. Hypertension. 2019;74(6):1420–1427. DOI: 10.1161/HYPERTENSIONAHA.119.13749
- Weiss J, Freeman M, Low A, Fu R, Kerfoot A, Paynter R, et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older: A systematic review and meta-analysis. Annals of Internal Medicine. 2017;166(6):419–429. DOI: 10.7326/M16-1754
- Bress AP, Greene T, Derington CG, Shen J, Xu Y, Zhang Y, et al. Patient selection for intensive blood pressure management based on benefit and adverse events. Journal of the American College of Cardiology. 2021;77(16):1977–1990. DOI: 10.1016/j.jacc.2021.02.058
DOI: https://doi.org/10.5334/gh.1415 | Journal eISSN: 2211-8179
Language: English
Submitted on: Apr 15, 2024
Accepted on: Feb 24, 2025
Published on: Mar 19, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Junichi Ishigami, Md. Mahmudul Hasan, Aruna Sarker, Sharmin Nahar, Sibly Sadik Shuvo, Mir Ishraquzzaman, Mohammad Abdullah Al Mamun, Md. Kalimuddin, Sheikh Mohammad Mahbubus Sobhan, Di Zhao, Kunihiro Matsushita, Lawrence J. Appel, Sohel Reza Choudhury, Edgar R. Miller III, Fazila-Tun-Nesa Malik, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.